Näytetään tulokset 1 - 10 / 532
tulosta / sivu
Mitä julkaisutietoja palvelu sisältää?
Julkaisun nimi
Tekijät
Julkaisukanava
Vuosi
 Julkaisujen tiedon ikoni

FDG‐PET/CT‐guided rebiopsy may find clinically unsuspicious transformation of follicular lymphoma

Vertaisarvioitu
Avoin saatavuus
DOI
10.1002/cam4.4924
Rajamäki, Aino; Kuitunen, Hanne; Sorigue, Marc; Kokkonen, Salla‐Maarit; Kuittinen, Outi; Sunela, Kai...
Cancer medicine2022 Julkaisujen tiedon ikoni

Female patients with follicular lymphoma have a better prognosis if primary remission lasts over 24 months

Vertaisarvioitu
Avoin saatavuus
DOI
10.1080/10428194.2021.1872073
Rajamäki, Aino; Sunela, Kaisa; Prusila, Roosa E. I.; Kuusisto, Milla E. L.; Mercadal, Santiago; Sela...
Leukemia & lymphoma2021 Julkaisujen tiedon ikoni

RIP1 has a role in CD40-mediated apoptosis in human follicular lymphoma cells

Vertaisarvioitu
Avoin saatavuus
DOI
10.1016/j.imbio.2017.06.001
Adem, Jemal; Eray, Mine; Eeva, Jonna; Nuutinen, Ulla; Pelkonen, Jukka
Immunobiology2017 Julkaisujen tiedon ikoni

Prognostic implications of the microenvironment for follicular lymphoma under immunomodulation therapy

Vertaisarvioitu
DOI
10.1111/bjh.16414
Menter, Thomas; Tzankov, Alexandar; Zucca, Emanuele; Kimby, Eva; Hultdin, Magnus; Sundström, Christe...
British journal of haematology2020 Julkaisujen tiedon ikoni

Total peroxiredoxin expression is associated with survival in patients with follicular lymphoma

Vertaisarvioitu
DOI
10.1007/s00428-016-1920-2
Peroja, Pekka; Haapasaari, Kirsi-Maria; Mannisto, Susanna; Miinalainen, Ilkka; Koivunen, Petri; Lepp...
Virchows archiv2016 Julkaisujen tiedon ikoni

Progression-free survival after front line, second line and third line in patients with follicular lymphoma treated in clinical practice

Vertaisarvioitu
Avoin saatavuus
DOI
10.2340/1651-226X.2024.24377
Rajamaki, Aino; Sorigue, Marc; Prusila, Roosa E I; Kuusisto, Milla E L; Kuitunen, Hanne; Jantunen, E...
Acta oncologica2024 Julkaisujen tiedon ikoni

Oxidative stress in diffuse large B-cell lymphoma and follicular lymphoma, and TP53 mutations and translocations of MYC, Bcl-2 and Bcl-6 in diffuse large B-cell lymphoma

Avoin saatavuus
Peroja, Pekka
Acta Universitatis Ouluensis. Series D, Medica2018 Julkaisujen tiedon ikoni

Robustness and pragmatism of the evidence supporting the European Society for Medical Oncology guidelines for the diagnosis, treatment, and follow-up of follicular lymphoma

Vertaisarvioitu
DOI
10.1080/17474086.2021.1943351
Sorigue, Marc; Kuittinen, Outi
Expert review of hematology2021 Julkaisujen tiedon ikoni

Risk of secondary haematological malignancies in patients with follicular lymphoma: an analysis of 1028 patients treated in the rituximab era.

Vertaisarvioitu
Avoin saatavuus
DOI
10.1111/bjh.16090
Prusila, Roosa E., I; Sorigue, Marc; Jauhiainen, Jyrki; Mercadal, Santiago; Postila, Aleksi; Salmi, ...
British journal of haematology2019 Julkaisujen tiedon ikoni

Reduced intensity allogeneic stem cell transplantation for follicular lymphoma relapsing after an autologous transplant achieves durable long-term disease control:an analysis from the Lymphoma Working Party of the EBMT

Vertaisarvioitu
DOI
10.1093/annonc/mdw124
Robinson, S. P.; Boumendil, A.; Finel, H.; Schouten, H.; Ehninger, G.; Maertens, J.; Crawley, C.; Ra...
Annals of oncology2016

FDG‐PET/CT‐guided rebiopsy may find clinically unsuspicious transformation of follicular lymphoma

Vertaisarvioitu
Avoin saatavuus
DOI
10.1002/cam4.4924
2022

Female patients with follicular lymphoma have a better prognosis if primary remission lasts over 24 months

Vertaisarvioitu
Avoin saatavuus
DOI
10.1080/10428194.2021.1872073
2021

RIP1 has a role in CD40-mediated apoptosis in human follicular lymphoma cells

Vertaisarvioitu
Avoin saatavuus
DOI
10.1016/j.imbio.2017.06.001
2017

Prognostic implications of the microenvironment for follicular lymphoma under immunomodulation therapy

Vertaisarvioitu
DOI
10.1111/bjh.16414
2020

Total peroxiredoxin expression is associated with survival in patients with follicular lymphoma

Vertaisarvioitu
DOI
10.1007/s00428-016-1920-2
2016

Progression-free survival after front line, second line and third line in patients with follicular lymphoma treated in clinical practice

Vertaisarvioitu
Avoin saatavuus
DOI
10.2340/1651-226X.2024.24377
2024

Oxidative stress in diffuse large B-cell lymphoma and follicular lymphoma, and TP53 mutations and translocations of MYC, Bcl-2 and Bcl-6 in diffuse large B-cell lymphoma

Avoin saatavuus
2018

Robustness and pragmatism of the evidence supporting the European Society for Medical Oncology guidelines for the diagnosis, treatment, and follow-up of follicular lymphoma

Vertaisarvioitu
DOI
10.1080/17474086.2021.1943351
2021

Risk of secondary haematological malignancies in patients with follicular lymphoma: an analysis of 1028 patients treated in the rituximab era.

Vertaisarvioitu
Avoin saatavuus
DOI
10.1111/bjh.16090
2019

Reduced intensity allogeneic stem cell transplantation for follicular lymphoma relapsing after an autologous transplant achieves durable long-term disease control:an analysis from the Lymphoma Working Party of the EBMT

Vertaisarvioitu
DOI
10.1093/annonc/mdw124
2016